Cardiovascular Rounds

News, resources, and analysis from the Cardiovascular Roundtable

How MemorialCare reduced care variation for ED chest pain patients

by Megan Tooley and Julie Bass June 13, 2018

A chest pain patient comes into your ED. What happens next? What tests do you run? Do you call for a cardiology consult? Do you admit them? For most programs, this is a common and challenging scenario.

Read more »

Looking for CV patients? Here's how to engage referring physicians and consumers.

by Megan Tooley and Julie Bass May 16, 2018

A recent Advisory Board analysis of almost 13,000 patients discovered that 86% of CV referrals are physician-driven. The analysis also found that patients can be surprisingly loyal to physician referrals—in fact, two-thirds of cardiac surgery patients said they would drive an hour to follow a physician referral to a specific surgeon, and almost one-quarter of patients said they would fly three hours.

Read more »

The strategy that can reduce your HF patients' mortality risk by 36%

by Megan Tooley, Marissa Schwartz and Ben Wheeler April 11, 2018

Cardiovascular disease (CVD) costs are estimated to skyrocket to $748.7 billion by 2035, with heart failure expected to play a significant role in that rise. With increased treatment costs, higher disease prevalence, and regulations tying more payments to episodic cost and quality on the horizon, hospitals and health systems need to become more effective in managing HF patients. 

Read more »

APP boot camp: Training today's advanced practice providers to be tomorrow's CV care team leaders

by Megan Tooley and Daniel Roza March 28, 2018

As hospitals find themselves stretched to meet the needs of an expanding patient population, ensuring top-of-license practice across the entire care team is essential. For the cardiovascular service line, that means giving more responsibilities to advanced practice providers (APPs) such as nurse practitioners and physician assistants.

Read more »

ECMO could significantly increase cardiac arrest survival rate. Here's what you need to know.

by Megan Tooley and Asya Igmen March 14, 2018

Every year, only 10% of the 350,000 people who suffer out-of-hospital cardiac arrest in the United States survive. The Ohio State University Wexner Medical Center recently adopted a protocol that may improve that rate to 40%, according to initial research.

Read more »

Our take on the big PCI controversy

By Megan Tooley, Aaron Mauck, and Sebastian Beckmann February 27, 2018

ORBITA, the double-blind, randomized control trial on percutaneous coronary intervention (PCI) in stable angina, revealed a worrying result: Researchers found that PCI was no better than a placebo in relieving participants' chest pain.

Both patient groups in the study underwent a rigorous medical optimization process, then half received a drug-eluting stent while the other half went through a sham intervention. While both cohorts saw an improvement in exercise capacity, reported chest pain, and quality of life In the six-week follow-up period, the PCI group performed no better than the placebo group.

Read more »

This Valentine's Day, get 3 lessons on optimizing your cardiac rehab program

Megan Tooley , Julie Bass February 13, 2018

While Feb. 14 is Valentine's Day, the cardiovascular community already has a full week of celebration planned: Feb. 11-17 marks AACVPR's National Cardiac Rehabilitation Week. We recently hosted a webconference, "How to Optimize Your Cardiac Rehab Program," with AACVPR (American Association of Cardiovascular and Pulmonary Rehabilitation) experts Tom Draper and Dr. Todd Brown. Here are three takeaways from the discussion.

Read more »

How Hartford Hospital adopted conscious sedation for TAVR

By Megan Tooley and Marissa Schwartz Schaffer January 4, 2018

Since its inception, TAVR has been one of the most exciting innovations in cardiovascular services. In recent years, TAVR has seen significant clinical advancements, leading both to better quality outcomes, and to opportunities for structural heart programs to become more efficient and cost-effective.

Indeed, with TAVR's burgeoning growth and positive forecasts for future volumes, achieving these dual aims of enhanced efficiency and high-quality outcomes will be imperative for structural heart programs to succeed.

Read more »

Comment Now

You must be logged in to comment